×
-0.0266429840142095 -0.0266429840142095 -0.0266429840142095 -0.0349319123741859 -0.0343398460627589 -0.0355239786856129 -0.0378922439313203 -0.0339846062759028
Stockreport

Mersana Therapeutics Outlines 2017 Milestones and 2018 Goals

MERSANA THERAPEUTICS (MRSN)  More Company Research Source: GlobeNewswire
Last mersana therapeutics earnings: 5/14 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: mersana.com/about-mersana
PDF CAMBRIDGE, Mass., Jan. 08, 2018 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc., (NASDAQ:MRSN) a clinical-stage biopharmaceutical company focused on discovering and developing a pipeline of antibody drug conjugates (ADCs) based on its Dolaflexin® and other proprietary platforms, today announced business and clinical achievements for 2017 and outlined corporate goals for 2018. The Company will provide further details during its presentation at the 36th Annual J.P. Morgan Healthcare Conference in San Francisco, CA on Wednesday, January 10, 2018 at 4:00 pm PT. “2017 was a year of exceptional execution as we positioned the company for achieving key clinical milestones in 2018 and beyond.  Last year, we advanced two lead ADC product candidates, XMT-1522 and XMT-1536, into the clinic and supported our partner Takeda in selecting its first Dolaflexin-based ADC for initiation of IND enabling studies,” said Anna Protopapas, President and CEO, Mersana Therapeutics. “We’re looking forward to 2 [Read more]

IMPACT SNAPSHOT EVENT TIME: MRSN
Last Price
Price Change
Price Change %
Volume Shares
Max Up
Max Down
Volume Ratio
%
Performance comparison Updated
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
LAST PRICE
VWAP
High:
MAX UP
High:
Low:
MAX DOWN
Low:
%
POST NEWS RANGE
%
PRICE CHANGE

PRICE CHANGE PERCENTAGE


S&P 500 (SPX)

%

VOLUME RATIO
%

VOLUME (SHARES)
TICKS

AVG SHARES PER TRADE

Don't Miss Out On The Next BIG Stock Move
EVENT DAY
Event Day Chart will not be displayed beyond 90-day period of the event
PERFORMANCE SINCE EVENT
TIME AND VELOCITY ANALYSIS